Blue Lizard Sheer Spf 50 Sunscreen

Titanium Dioxide, Zinc Oxide


Crown Laboratories
Human Otc Drug
NDC 0316-2064
Blue Lizard Sheer Spf 50 Sunscreen also known as Titanium Dioxide, Zinc Oxide is a human otc drug labeled by 'Crown Laboratories'. National Drug Code (NDC) number for Blue Lizard Sheer Spf 50 Sunscreen is 0316-2064. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Blue Lizard Sheer Spf 50 Sunscreen drug includes Titanium Dioxide - 99.9 mg/mL Zinc Oxide - 66.6 mg/mL . The currest status of Blue Lizard Sheer Spf 50 Sunscreen drug is Active.

Drug Information:

Drug NDC: 0316-2064
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Blue Lizard Sheer Spf 50 Sunscreen
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Titanium Dioxide, Zinc Oxide
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Crown Laboratories
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Lotion
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:TITANIUM DIOXIDE - 99.9 mg/mL
ZINC OXIDE - 66.6 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 06 May, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Crown Laboratories
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:15FIX9V2JP
SOI2LOH54Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0316-2064-301 TUBE in 1 CARTON (0316-2064-30) / 89 mL in 1 TUBE06 May, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose sunscreen

Uses helps prevent sunburn and photodamage caused by uva/uvb exposure higher spf gives more sunburn protection if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Product Elements:

Blue lizard sheer spf 50 sunscreen titanium dioxide, zinc oxide glycerin hamamelis virginiana leaf ginkgo aloe vera leaf aluminum oxide aluminum stearate shea butter alkyl (c12-15) benzoate medium-chain triglycerides papaya citric acid monohydrate orange peel crithmum maritimum whole cucumber diisopropyl sebacate dimethoxydiphenylsilane triethoxycaprylylsilane ethylhexylglycerin fucus vesiculosus .gamma.-nonalactone zinc oxide zinc oxide titanium dioxide titanium dioxide hydrogenated palm oil hydrogenated rapeseed oil isostearyl isostearate potassium sorbate water castor oil sclerocarya birrea seed oil sodium chloride sorbitan isostearate triethyl citrate xanthan gum squalane polyglyceryl-3 pentaricinoleate .alpha.-tocopherol acetate isostearyl alcohol phenoxyethanol polyhydroxystearic acid (2300 mw) rosa canina fruit oil sodium benzoate

Warnings:

Warnings when using this product keep out of eyes. rinse with water to remove stop use and ask a doctor if rash or irritation occurs do not use on damaged or broken skin if allergic to any ingredient if swallowed, get medical help or contact a poison control center

Package Label Principal Display Panel:

Blue lizard sheer lotion - tube label blue lizard australian sunscreen 50+ sheer lotion mineral sunscreen uva/uvb protection broad spectrum spf 50+ water resistant (80 minutes) p11899.00 sheer-body-tube

Blue lizard sheer lotion - 3oz carton blue lizard australian sunscreen 50+ sheer lotion mineral sunscreen uva/uvb protection broad spectrum spf 50+ water resistant (80 minutes) p11902.01 p1190201

Further Questions:

Questions? visit www.bluelizardsunscreen.com or call 800.877.8869 crown laboratories, inc., johnson city, tn 37604


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.